Free colloquium at UC San Diego explores bioengineering in the 21st Century

July 19, 2000

Three experts from industry, government and the university will come together on August 9 to provide insights into bioengineering, a field critical to future medical advances. The Colloquium on the Perspectives of Bioengineering will be held from 2 p.m. to 3:30 p.m. in UCSD¹s Price Center Ballroom, and precedes the groundbreaking of the Powell-Focht Bioengineering Hall at the Jacobs School of Engineering. Sponsored by the Jacobs School, this free public lecture is a wonderful opportunity to gain valuable knowledge presented by some of bioengineering¹s premier leaders.

Free parking and shuttle service for the event will be available in UC San Diego Lot 705. From Interstate 5, exit Genesee and head East to Campus Point Drive. Turn Right on Campus Point Drive and left on Voigt Drive to Lot 705. For more information, contact Elizabeth Hickman at 858-822-2290.

The speakers include Wendy Baldwin, Deputy Director for Extramural Research at the National Institutes of Health and Chair of the Bioengineering Consortium (BENCON); Duane Roth, Chief Executive Officer, Alliance Pharmaceutical Corporation; and Shu Chien, Professor of Bioengineering and Medicine, and Director of the Whitaker Institute of Biomedical Engineering. Dr. Baldwin¹s lecture will address ³The future of bioengineering at the National Institutes of Health.² Roth¹s lecture will cover ³Perspectives on the role of bioengineering in industry.² And Dr. Chien¹s will focus on ³Perspectives on bioengineering at UCSD and beyond.²

Bioengineering is an interdisciplinary field in which the principles and tools of traditional engineering fields are applied to biomedical problems. Engineering plays an increasingly important role in medicine with projects that range from basic research in physiology to advances in biotechnology and the improvement of health care delivery.

University of California - San Diego

Related Engineering Articles from Brightsurf:

Re-engineering antibodies for COVID-19
Catholic University of America researcher uses 'in silico' analysis to fast-track passive immunity

Next frontier in bacterial engineering
A new technique overcomes a serious hurdle in the field of bacterial design and engineering.

COVID-19 and the role of tissue engineering
Tissue engineering has a unique set of tools and technologies for developing preventive strategies, diagnostics, and treatments that can play an important role during the ongoing COVID-19 pandemic.

Engineering the meniscus
Damage to the meniscus is common, but there remains an unmet need for improved restorative therapies that can overcome poor healing in the avascular regions.

Artificially engineering the intestine
Short bowel syndrome is a debilitating condition with few treatment options, and these treatments have limited efficacy.

Reverse engineering the fireworks of life
An interdisciplinary team of Princeton researchers has successfully reverse engineered the components and sequence of events that lead to microtubule branching.

New method for engineering metabolic pathways
Two approaches provide a faster way to create enzymes and analyze their reactions, leading to the design of more complex molecules.

Engineering for high-speed devices
A research team from the University of Delaware has developed cutting-edge technology for photonics devices that could enable faster communications between phones and computers.

Breakthrough in blood vessel engineering
Growing functional blood vessel networks is no easy task. Previously, other groups have made networks that span millimeters in size.

Next-gen batteries possible with new engineering approach
Dramatically longer-lasting, faster-charging and safer lithium metal batteries may be possible, according to Penn State research, recently published in Nature Energy.

Read More: Engineering News and Engineering Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to